Ligand validation:9BY4

PDO: 1,3-PROPANDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9BY4_PDO_A_1304	40%	81%	0.174	0.886	0.33	0.48	-	-	0	0	100%	1
9BY4_PDO_A_1305	25%	82%	0.239	0.876	0.31	0.48	-	-	1	0	100%	1
9BY4_PDO_A_1301	15%	90%	0.258	0.819	0.33	0.29	-	-	2	0	100%	1
9BY6_PDO_A_1301	20%	86%	0.236	0.839	0.34	0.38	-	-	2	0	100%	1
6BUM_PDO_C_403	90%	90%	0.094	0.976	0.36	0.26	-	-	0	0	100%	1
6BUN_PDO_C_405	87%	89%	0.094	0.967	0.54	0.12	-	-	0	0	100%	1
1ZV9_PDO_A_3001	84%	87%	0.098	0.961	0.3	0.39	-	-	2	0	100%	1
6BUP_PDO_B_404	80%	84%	0.12	0.97	0.27	0.48	-	-	0	0	100%	1
4HON_PDO_A_416	79%	77%	0.107	0.954	0.41	0.52	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.